October, 28 2008, 09:39am EDT
Kucinich Continues Investigation of Bail-Out Bonuses
Requests Full Committee Resources to Be Used
WASHINGTON
Congressman Dennis Kucinich, Chairman of the Subcommittee on Domestic Policy is pressing his efforts to head off an avalanche of Wall Street bailout bonuses. Recent reports indicate bonuses and other compensation packages paid by financially troubled firms receiving government assistance could reach into the tens of billions of dollars.
Today he released a letter sent to Congressman Henry Waxman, Chairman of the Committee on Oversight and Government Reform, asking that the Full Committee move quickly to investigate how bailout funds are being spent by the financial service companies participating in Treasury's capital purchase program.
"It would be an affront to taxpayers and shareholders alike if Wall Street executives cashed in on the bailout. We must prevent the diverted directly or indirectly of bailout funds to bonuses and exorbitant compensation packages," he said.
Congressman Kucinich, an opponent to the bailout, has been a leader in calling for stringent oversight on money spent through the bailout program. He asked for the leadership of the Full Committee to ensure that the resources necessary to investigate are available. The Subcommittee will remain a key part of the investigation.
Congressman Kucinich recommended that the Full Committee begin by requesting specific information from each of the 11 companies participating in the Treasury's Capital Purchase Program (Bank of America, Citigroup, J.P. Morgan Chase, Wells Fargo, Morgan Stanley, Goldman Sachs, Merrill Lynch, Bank of New York Mellon, State Street, City National, and Key Bank). The information requested would include compensation data since 2003, descriptions of 'claw back' policies, an itemized list of funds received from government sources, A list of every party who has purchased more than $50 million of impaired assets in the past 24 months, and a description of each organizations risk management procedures.
"I believe that the American taxpayers who have provided this subsidy have legitimate concerns about how those companies will use those funds, what happened to require them to need those funds, and what they will be doing differently in the future to ensure that they will not need more assistance," wrote Kucinich in the letter.
The full text of the letter follows:
October 27, 2008
Henry A. Waxman, Chairman
Oversight and Government Reform Committee
2157 Rayburn HOB
Washington, DC 20515
Dear Henry:
I am writing to ask that the Full Committee move quickly to conduct oversight on the use of Federal monies by financial service companies participating in the Treasury's Capital Purchase program. As you know, Treasury has set aside $250 billion for buying preferred equity in a number of national and regional financial institutions with funds authorized by the Emergency Economic Stabilization Act of 2008, passed recently by Congress.
While the ostensible purpose of these purchases is to increase lending by these institutions, it is not a requirement. Indeed, these companies are arguably free to spend these funds, or existing funds freed by the federal cash infusion, for any purpose, including payment of bonuses and extravagant compensation earned during the period preceding the bailout.
I believe that the American taxpayers who have provided this subsidy have legitimate concerns about how those companies will use those funds, what happened to require them to need those funds, and what they will be doing differently in the future to ensure that they will not need more assistance. Furthermore, this matter requires the urgent attention of the Committee, since the recipients of the federal monies can be expected to commit those funds immediately.
In view of the urgent nature of this matter, I will commit the resources of my subcommittee to follow the lead of the Full Committee in this investigation and assist in any way requested. I suggest that the Committee begin by requesting the following information from each of the 11 companies participating in Treasury's Capital Purchase program (Bank of America; Citigroup; J.P. Morgan Chase; Wells Fargo; Morgan Stanley; Goldman, Sachs; Merrill Lynch; Bank of New York Mellon; State Street; City National, and Key Bank):
1. A breakdown of the total annual compensation paid since 2003 through the present, including plans to pay compensation and bonuses in the near future for performance prior to the capital purchase; to each employee whose total annual income exceeded $500,000. They should be asked to name the top five executives and break down their compensation packages. (They should include executive level employees who are no longer employed by the company). They should be asked to aggregate figures for the remaining individuals receiving over $500,000, by placing them into the following groups: over $1,000,000, between $750,000 and $999,999, and between $500,000 and $749,999. Total annual compensation should mean: salary, bonus, other compensation, the value of restricted stock awards, long-term incentive payouts and the value of stock option awards in the fiscal year. Other compensation includes perquisites and other personal benefits; amounts accrued pursuant to a termination or change in control plan; annual company contributions to vested and unvested pension plans; the dollar value of any insurance premiums paid by the company with respect to life insurance for the benefit of an employee; gross-ups or other reimbursements for taxes; and discounted securities purchases.
2. A description of any policies in place that dictate the circumstances in which the company will seek to recoup, "clawback", compensation paid to employees in the event of a significant restatement of financial results or significant extraordinary write-off. If the company has entered into indemnification agreements or purchased insurance on behalf of certain employees to shield them from personal losses resulting from clawback obligations, they should be asked to explain the terms of such agreements or policies; limits, if any, on the amount that may be reimbursed to the company on behalf of the employment; the applicable standard of conduct that will override the agreement or insurance; and each individual who is covered by such agreements or insurance.
3. An itemized list of all government funds they have received since January 1, 2007 through Treasury programs. the anticipated benefit they expect to recognize as a result of the tax change enacted in Section 301 of the Emergency Economic Stabilization Act of 2008, participation in any Federal Reserve liquidity facility created after January 1, 2008, interest payments they have received from the Federal Reserve, and loans they have received to purchase assets from pooled investment vehicles under their control.
4. A list of the types of collateral they have pledged to each of these facilities and the value they received in exchange, if their institution has accessed any of the primary dealer credit facilities. They should indicate the aggregate value they have received each month in exchange for each type of collateral including treasury securities, agency securities, AAA-rated mortgage-backed, AAA-rated asset-backed securities, investment grade corporate securities, investment grade municipal securities, investment grade mortgage-backed securities, and investment grade asset-backed securities.
5. A list of every party who has purchased more than $50 million of impaired assets from their organization in the past 24 months and any financing they have provided.
6. An explanation of why the institutions participating in the Capital Purchase program need government aid. They should describe their business strategy going forward and how it differs from the strategy that has made it necessary for them to accept government aid.
7. A description of the organization's risk management procedures before they received government aid and the improvements they have made in light of the consequences to their organization of the financial crisis.
This would be a logical extension of the recent oversight conducted by the Full Committee on executive compensation and key actors in the financial crisis.
Sincerely,
Dennis J. Kucinich
Chairman
Domestic Policy Subcommittee
Enclosure
cc: Darrell Issa
Ranking Minority Member
Dennis Kucinich is an American politician. A U.S. Representative from Ohio from 1997 to 2013, he was also a candidate for the Democratic nomination for president of the United States in 2004 and 2008.
LATEST NEWS
Dems Demand Answers as Trump Photo Disappears From DOJ Online Epstein Files
"What else is being covered up?"
Dec 20, 2025
Congressional Democrats on Saturday pressed US Attorney General Pam Bondi for answers regarding the apparent removal of a photo showing President Donald Trump surrounded by young female models from Friday's Department of Justice release of files related to the late convicted child sex criminal Jeffrey Epstein.
Amid the heavily redacted documents in Friday's DOJ release was a photo of a desk with an open drawer containing multiple photos of Trump, including one of him with Epstein and convicted child sex trafficker Ghislaine Maxwell and another of him with the models.
However, the photo—labeled EFTA00000468 in the DOJ's Epstein Library—was no longer on the site as of Saturday morning.
"This photo, file 468, from the Epstein files that includes Donald Trump, has apparently now been removed from the DOJ release," Democrats on the House Oversight Committee noted in a Bluesky post. "AG Bondi, is this true? What else is being covered up? We need transparency for the American public."
This photo, file 468, from the Epstein files that includes Donald Trump has apparently now been removed from the DOJ release.AG Bondi, is this true? What else is being covered up? We need transparency for the American public.
[image or embed]
— Oversight Dems (@oversightdemocrats.house.gov) December 20, 2025 at 9:30 AM
Numerous critics have accused the Trump administration of a cover-up due to the DOJ's failure to meet a Friday deadline to release all Epstein-related documents and heavy redactions—including documents of 100 pages or more that are completely blacked out—to many of the files.
Deputy Attorney General Todd Blanche responded to the criticism by claiming that "the only redactions being applied to the documents are those required by law—full stop."
"Consistent with the statute and applicable laws, we are not redacting the names of individuals or politicians unless they are a victim," he added.
Earlier this year, officials at the Federal Bureau of Investigation reportedly redacted Trump's name from its file on Epstein, who was the president's longtime former friend and who died in 2019 in a New York City jail cell under mysterious circumstances officially called suicide while facing federal child sex trafficking and conspiracy charges.
Trump has not been accused of any crimes in connection with Epstein.
House Oversight Committee Ranking Member Robert Garcia (D-Calif.) said during a Friday CNN interview that the DOJ only released about 10% of the full Epstein files.
The DOJ is breaking the law by not releasing the full Epstein files. This is not transparency. This is just more coverup by Donald Trump and Pam Bondi. They need to release all the files, NOW.
[image or embed]
— Congressman Robert Garcia (@robertgarcia.house.gov) December 19, 2025 at 5:06 PM
"The DOJ has had months and hundreds of agents to put these files together, and yet entire documents are redacted—from the first word to the last," Garcia said on X. "What are they hiding? The American public deserves transparency. Release all the files now!"
In a joint statement Friday, Garcia and House Judiciary Committee Ranking Member Jamie Raskin (D-Md.) said, "We are now examining all legal options in the face of this violation of federal law."
"The survivors of this nightmare deserve justice, the co-conspirators must be held accountable, and the American people deserve complete transparency from DOJ," they added.
Rep. Ro Khanna (D-Calif.)—who along with Rep. Thomas Massie (R-Ky.) introduced the Epstein Files Transparency Act, which was signed into law by Trump last month and required the release of all Epstein materials by December 19—said in a video published after Friday's document dump that he and Massie "are exploring all options" to hold administration officials accountable.
"It can be the impeachment of people at Justice, inherent contempt, or referring for prosecution those who are obstructing justice," he added.
Keep ReadingShow Less
Israeli Forces Massacre 6 Palestinians Celebrating Wedding at Gaza School Shelter
"This isn't a truce, it's a bloodbath," said a relative of some of the victims, who included women, an infant, and a teenage girl.
Dec 20, 2025
Funerals were held Saturday in northern Gaza for six people, including children, massacred the previous day by Israeli tank fire during a wedding celebration at a school sheltering displaced people, as the number of Palestinians killed during the tenuous 10-week ceasefire rose to over 400.
On Friday, an Israel Defense Forces (IDF) tank blasted the second floor of the Gaza Martyrs School, which was housing Palestinians displaced by the two-year war on Gaza in the al-Tuffah neighborhood of Gaza City.
Al Jazeera and other news outlets reported that the attack occurred while people were celebrating a wedding.
Al-Shifa Hospital director Mohammed Abou Salmiya said those slain included a 4-month-old infant, a 14-year-old girl, and two women. At least five others were injured in the attack.
"It was a safe area and a safe school and suddenly... they began firing shells without warning, targeting women, children and civilians," Abdullah Al-Nader—who lost relatives including 4-month-old Ahmed Al-Nader in the attack—told Agence France-Presse.
Witnesses said IDF troops subsequently blocked first responders including ambulances and civil defense personnel from reaching the site for over two hours.
"We gathered the remains of children, elderly, infants, women, and young people," Nafiz al-Nader, another relative of the infant and others killed in Friday's attack, told reporters. "Unfortunately, we called the ambulance and the civil defense, but they couldn't get by the Israeli army."
The IDF said that “during operational activity in the area of the Yellow Line in the northern Gaza Strip, a number of suspicious individuals were identified in command structures," and that "troops fired at the suspicious individuals to eliminate the threat."
The Yellow Line is a demarcation boundary between areas of Gaza under active Israeli occupation—more than half of the strip's territory, including most agricultural and strategic lands—and those under the control of Hamas.
"The claim of casualties in the area is familiar; the incident is under investigation," the IDF said, adding that it "regrets any harm to uninvolved parties and acts as much as possible to minimize harm to them."
Since the October 7, 2023 Hamas-led attack on Israel, more than 250,000 Palestinians have been killed or wounded by Israeli forces, including approximately 9,500 people who are missing and presumed dead and buried beneath rubble. Classified IDF documents suggest that more than 80% of the Palestinians killed by Israeli forces were civilians.
Around 2 million Palestinians have also been displaced—on average, six times—starved, or sickened in the strip.
Gaza officials say at least 401 Palestinians have been killed since a US-brokered ceasefire between Israel and Hamas took effect on October 10. Gaza's Government Media Office says Israel has violated the ceasefire at least 738 times.
"This isn't a truce, it's a bloodbath," Nafiz al-Nader told Agence France-Presse outside al-Shifa Hospital on Saturday.
Israel says Hamas broke the truce at least 32 times, with three IDF soldiers killed during the ceasefire.
Israeli Prime Minister Benjamin Netanyahu and Yoav Gallant, his former defense minister, are fugitives from the International Criminal Court in The Hague, where they are wanted for alleged war crimes and crimes against humanity in Gaza, including murder and forced starvation.
Israel is also facing a genocide case filed by South Africa at the International Court of Justice, also in The Hague. A United Nations commission, world leaders, Israeli and international human rights groups, jurists, and scholars from around the world have called Israel's war on Gaza a genocide.
Friday's massacre came as Steve Witkoff, President Donald Trump's Mideast envoy, other senior US officials, and representatives of Egypt, Qatar, Turkey, and the United Arab Emirates met in Miami to discuss the second phase of Trump's peace plan, which includes the deployment of an international stabilization force, disarming Hamas, the withdrawal of IDF troops from the strip, and the establishment of a new government there.
Keep ReadingShow Less
Trump's 9 New Prescription Drug Deals 'No Substitute' for Systemic Reform
"Patients are overwhelmingly calling on Congress to do more to lower prescription drug prices by holding Big Pharma accountable and addressing the root causes of high drug prices," said one campaigner.
Dec 19, 2025
"Starting next year, American drug prices will come down fast and furious and will soon be the lowest in the developed world," President Donald Trump claimed Friday as the White House announced agreements with nine pharmaceutical manufacturers.
The administration struck most favored nation (MFN) pricing deals with Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead Sciences, GSK, Merck, Novartis, and Sanofi. The president—who has launched the related TrumpRx.gov—previously reached agreements with AstraZeneca, EMD Serono, Eli Lilly, Novo Nordisk, and Pfizer.
"The White House said it has made MFN deals with 14 of the 17 biggest drug manufacturers in the world," CBS News noted Friday. "The three drugmakers that were not part of the announcement are AbbVie, Johnson & Johnson, and Regeneron, but the president said that deals involving the remaining three could be announced at another time."
However, as Trump and congressional Republicans move to kick millions of Americans off of Medicaid and potentially leave millions more uninsured because they can't afford skyrocketing premiums for Affordable Care Act (ACA) plans, some critics suggested that the new drug deals with Big Pharma are far from enough.
"When 47% of Americans are concerned they won't be able to afford a healthcare cost next year, steps to reduce drug prices for patients are welcomed, especially by patients who rely on one of the overpriced essential medicines named in today's announcement," said Merith Basey, CEO of Patients for Affordable Drugs Now, in a statement.
"But voluntary agreements with drug companies—especially when key details remain undisclosed—are no substitute for durable, system-wide reforms," Basey stressed. "Patients are overwhelmingly calling on Congress to do more to lower prescription drug prices by holding Big Pharma accountable and addressing the root causes of high drug prices, because drugs don't work if people can't afford them."
As the New York Times reported Friday:
Drugs that will be made available in this way include Amgen's Repatha, for lowering cholesterol, at $239 a month; GSK's asthma inhaler, Advair Diskus, at $89 a month; and Merck's diabetes medication Januvia, at $100 a month.
Many of these drugs are nearing the end of their patent protection, meaning that the arrival of low-cost generic competition would soon have prompted manufacturers to lower their prices.
In other cases, the direct-buy offerings are very expensive and out of reach for most Americans.
For example, Gilead will offer Epclusa, a three-month regimen of pills that cures hepatitis C, for $2,492 a month on the site. Most patients pay far less using insurance or with help from patient assistance programs. Gilead says on its website that "typically a person taking Epclusa pays between $0 and $5 per month" with commercial insurance or Medicare.
While medication prices are a concern for Americans who face rising costs for everything from groceries to utility bills, the outcome of the ongoing battle on Capitol Hill over ACA tax credits—which are set to expire at the end of the year—is expected to determine how many people can even afford to buy health insurance for next year.
The ACA subsidies fight—which Republicans in the US House of Representatives ignored in the bill they passed this week before leaving Capitol Hill early—has renewed calls for transitioning the United States from its current for-profit healthcare system to Medicare for All.
"At the heart of our healthcare crisis is one simple truth: Corporations have too much power over our lives," Rep. Pramila Jayapal (D-Wash.), former chair of the Congressional Progressive Caucus, said on social media Friday. "Medicare for All is how we take our power back and build a system that puts people over profits."
Jayapal reintroduced the Medicare for All Act in April with Rep. Debbie Dingell (D-Mich.) and Senate Health, Education, Labor, and Pensions Committee Ranking Member Bernie Sanders (I-Vt.). The senator said Friday that some of his top priorities in 2026 will be campaign finance reform, income and wealth inequality, the rapid deployment of artificial intelligence, and Medicare for All.
Earlier this month, another backer of that bill, US Sen. Chris Van Hollen (D-Md.), said: "We must stop tinkering around the edges of a broken healthcare system. Yes, let's extend the ACA tax credits to prevent a huge spike in healthcare costs for millions. Then, let's finally create a system that puts your health over corporate profits. We need Medicare for All."
It's not just progressives in Congress demanding that kind of transformation. According to Data for Progress polling results released late last month, 65% of likely US voters—including 78% of Democrats, 71% of Independents, and 49% of Republicans—either strongly or somewhat support "creating a national health insurance program, sometimes called 'Medicare for All.'"
Keep ReadingShow Less
Most Popular


